# Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients

> **NCT04148001** · — · COMPLETED · sponsor: **REGENXBIO Inc.** · enrollment: 4 (actual)

## Conditions studied

- Homozygous Familial Hypercholesterolemia (HoFH)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04148001
- **Lead sponsor:** REGENXBIO Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-04
- **Primary completion:** 2020-04-08
- **Final completion:** 2020-04-08
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2021-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04148001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04148001, "Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04148001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*